Biotricity is trading 11.43% down at $0.06 on September 28, 2026, with no company-specific announcement or confirmed catalyst identified.

  • The company’s latest listed press release is dated February 11, 2026.
  • In the supplied market context, the Nasdaq is down 0.72% and the S&P 500 is down 0.50%. Those declines may add pressure but do not establish a direct cause for Biotricity’s larger move.